Member access

4-Traders Homepage  >  Shares  >  Toronto Stock Exchange  >  Cardiome Pharma Corp.    COM   CA14159U3010

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Toronto Stock Exchange
03/23/2015 03/24/2015 03/25/2015 03/26/2015 03/27/2015 Date
10.45 10.68 10.35 9.92 10.52 Last
9687 15102 1828 21795 17555 Volume
-1.69% +2.20% -3.09% -4.15% +6.05% Change
Financials ( CAD)
Sales 2015 42,7 M
EBIT 2015 -14,3 M
Net income 2015 -5,57 M
Debt 2015 -
Yield 2015 -
Sales 2016 54,8 M
EBIT 2016 -7,37 M
Net income 2016 0,43 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 4,15x
Capi. / Sales 2016 3,23x
Capitalization 177 M
More Financials
Company
Cardiome Pharma Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of new therapies that will improve the health of patients around the world.Its product BrinavessTM approved in Europe and other territories for the rapid conversion of recent... 
Sector
Pharmaceuticals
Calendar
05/11Earnings Release
More about the company
Surperformance© ratings of Cardiome Pharma Corp.
Trading Rating : Investor Rating :
More Ratings
Latest news on CARDIOME PHARMA CORP.
03/12 CARDIOME PHARMA : reports fourth quarter and full year 2014 financial results
03/05 CARDIOME PHARMA : to Hold Fourth Quarter and Full Year 2014 Financial Results Co..
2014 CARDIOME PHARMA : Enters Development And Commercialization Agreement With Edding..
2014 CARDIOME PHARMA : Enters Development and Commercialization Agreement with Edding..
2014 CARDIOME PHARMA : Enters Commercialization Agreement With Aspen For Brinavess In..
2014 CARDIOME PHARMA : Enters Commercialization Agreement with Aspen for BRINAVESS® i..
2014 CARDIOME PHARMA : Submits BRINAVESS® Reimbursement Dossier to Italian Authoritie..
2014 CARDIOME PHARMA : Reports Third Quarter 2014 Financial Results
More news
Sector news : Biopharmaceuticals
03/27 HOSPIRA : first biosimilar could be its first to gain FDA approval
03/27 VALEANT PHARMACEUTICALS INTL : S&P Dow Jones Indices Announces Changes to the S&..
03/27DJGilead Sciences CEO's Pay Rose 23% Last Year
More sector news : Biopharmaceuticals
News from SeekingAlpha
03/12 Cardiome Pharma's (CRME) CEO William Hunter on Q4 2014 Results - Earnings Cal..
03/12 Cardiome Pharma misses by $0.25, misses on revenue
03/11 Notable earnings before Thursday?s open


Comments 
Advertisement
Chart CARDIOME PHARMA CORP.
Duration : Period :
Cardiome Pharma Corp. Technical Analysis Chart | COM | CA14159U3010 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF